TP53 and lung cancer: First, we performed siRNA-mediated silencing of SBDS in several wild-type p53-sustaining cancer cell lines, including colorectal cancer cell line HCT116p53+/+, lung cancer cell line H460 and melanoma cell line SK-MEL-147 (Fig. 2a–c).